Revolution Medicines (RVMD) Net Margin Growth (3y) (2022 - 2023)

Revolution Medicines (RVMD) Net Margin Growth (3y) (2022 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 9,283.00
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 506.00
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -569.00
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 4,144.00
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 7,218.00

Historic Data

Download Data
DateValue
Dec 31, 2023 -2.14 Mn
Jun 30, 2023 -229,908.00
Mar 31, 2023 -78,261.00
Dec 31, 2022 -21,282.00
Sep 30, 2022 -204,856.00
Jun 30, 2022 -56,425.00
Mar 31, 2022 -66,344.00